Microsoft and 3 Dow 30 Giants Making Moves
Merck & Co. Inc. (NYSE:MRK) is among the drug majors upon which BMO begins coverage Friday (Market Perform), along with Eli Lilly (NYSE:LLY) at the same rating. Bristol-Myers (NYSE:BMY) begins with Outperform.
Don’t Miss: Apple: We’re Cleaning Up the Cloud.
Pfizer Inc. (NYSE:PFE) reported the results of studies on Lyrica capsules CV presented at the American Pain Society Annual Meeting in Honolulu. Exploratory research was included in the trials to provide new insights into how Lyrica works in the brains of patients with fibromyalgia; in all, Lyrica abstracts were presented. In this exploratory reserch, Lyrica reduced connectivity between various parts of the brain involved in pain processing, an important effect since fibromyalgia patients have elevated intrinsic connectivity. In an additional fMRI analysis, Lyrica was found to affect density in parts of the brain that are known to process pain. In this study, the most common side effect in Lyrica-treated patients was dizziness when compared with those given a placebo.
Wal-Mart Stores Inc. (NYSE:WMT) implied in an SEC filing that it is looking into possible bribery and other misconduct by its officials in places other than in Mexico, says the New York Times. The company said that it’s investigating potential violations of the Foreign Corrupt Practices Act and “…other alleged crimes or misconduct in connection with foreign subsidiaries, including Wal-Mart de Mexico”.
Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.
Don’t Miss: Is Facebook Stealing Apple’s Thunder?